Multibagger Returns in Just 3 Months: Microcap Company Reports 141 Per cent Growth in Monthly Sales in August; Stock Hits Upper Circuit on Thursday!

Rakesh Deshmukh
Multibagger Returns in Just 3 Months: Microcap Company Reports 141 Per cent Growth in Monthly Sales in August; Stock Hits Upper Circuit on Thursday!

The company’s shares have delivered an impressive return of over 115 per cent in just 3 months.

GSM Foils Limited, which specializes in the manufacturing of blister foils and aluminium pharma foils for pharmaceutical packaging, offers products ranging from 20 to 40 microns in thickness, suitable for coated, poly-laminated, blister, and printed foils.

The company’s stock hit the upper circuit today after updating its monthly sales volume. According to the company's latest announcement, their sales volume for August 2024 reached Rs 10,72,90,984 compared to Rs 4,44,96,209 representing a growth of 141 per cent. Net Sales for April-August 2024 2024 stands at Rs 40,81,46,012.

Today, the shares of GSM Foils Limited hit the upper circuit and currently, they are at around Rs 65.65 per share on the NSE. The company’s current market capitalization stands at Rs 84.11 crore. Addtionally, the shares have delivered a multibagger return of over 115 per cent in just 3 months.

DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.

Read GSM Foils Ltd's July Month Update!

The company’s IPO launched in the month of May 2024 at Rs 32 each with a face value of Rs 10 each. The promoter holding pre-IPO was 99.99 per cent which is now reduced to 73.14 per cent after the IPO.

The company operates a 7,973-square-foot manufacturing facility located in the Sapphire Building in Thane, Vasai, Maharashtra. This ground-plus three-floor facility is fully equipped to handle all aspects of the production process, including seamless manufacturing, quality testing, research, storage, and packaging. In terms of revenue distribution, blister foils contribute 63 per cent of the company's revenue, while pharma foils account for the remaining 37 per cent. Geographically, the company has a strong presence across India, serving clients in 13 states and one Union Territory.

Check out my recent article here.

Investors must keep this stock on their radar.

Disclaimer: The article is for informational purposes only and not investment advice.

Rate this article:
4.0

DSIJ MINDSHARE

Mkt Commentary20-Dec, 2024

Swing Trading22-Dec, 2024

IPO Analysis20-Dec, 2024

Mindshare20-Dec, 2024

IPO Analysis20-Dec, 2024

Knowledge

MF15-Nov, 2024

General15-Nov, 2024

MF14-Nov, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR